Leisser, C.
Kanclerz, P.
Ruiss, M.
Pilwachs, C.
Hienert, J.
Findl, O.
Article History
Received: 20 September 2023
Accepted: 18 November 2023
First Online: 15 January 2024
Declarations
:
: O. Findl is a scientific advisor for Alcon, Croma, Carl Zeiss Meditec AG, and Johnson & Johnson, but has no personal interest in the products mentioned. C. Leisser, P. Kanclerz, M. Ruiss, C. Pilwachs and J. Hienert declare that they have no competing interests.
: All research and measurements followed the tenets of The Declaration of Helsinki and were approved by the local ethics committee of the city of Vienna (clinical trial registration: NCT03328715). Written informed consent was obtained from all patients in the study.